TP53 and sarcoma: Historically known as Li–Fraumeni Syndrome, and SBLA syndrome due to its association with sarcomas, breast, leukemia, adrenal gland cancers before the age of 45, the syndrome has been expanded to the TP53-related cancer syndrome (hPT53c) due to its associated with a myriad of other malignancies [19].